Tianbao Lu
Impact in
- Organic Chemistry top 5%
- Click Chemistry and Applications
- Multicomponent Synthesis of Heterocycles
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
-
- Chemical Synthesis and Analysis 8
- Ubiquitin and proteasome pathways 2
- Oncology 10
- Cancer-related Molecular Pathways 8
- Co-authors
- Daniel J. Parks (9 shared papers)Maxwell D. Cummings (8 shared papers)Karen L. Milkiewicz (7 shared papers)Raul R. Calvo (6 shared papers)Jennifer Lattanze (6 shared papers)Juan Marugán (6 shared papers)Louis V. LaFrance (4 shared papers)Mark R. Player (9 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (14 papers)Journal of Medicinal Chemistry (4 papers)Cancer Research (3 papers)Tetrahedron Letters (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesChinaBelgium
In The Last Decade
Tianbao Lu
36 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 83
- Organic Chemistry 432
- Oncology 337
- Pharmaceutical Science 62
- Hematology 103
- Biotechnology 78
Countries citing papers authored by Tianbao Lu
This map shows the geographic impact of Tianbao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianbao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianbao Lu more than expected).
Fields of papers citing papers by Tianbao Lu
This network shows the impact of papers produced by Tianbao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianbao Lu. The network helps show where Tianbao Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Tianbao Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 139 | |
| 2 | 2004 | 139 | |
| 3 | 2005 | 61 | |
| 4 | 2006 | 60 | |
| 5 | 2006 | 50 | |
| 6 | 2017 | 48 | |
| 7 | 2007 | 48 | |
| 8 | 2005 | 45 | |
| 9 | 2006 | 39 | |
| 10 | 2007 | 39 | |
| 11 | 2015 | 38 | |
| 12 | 2010 | 30 | |
| 13 | 2008 | 29 | |
| 14 | 2008 | 28 | |
| 15 | 2006 | 26 | |
| 16 | 2016 | 26 | |
| 17 | 2003 | 25 | |
| 18 | 1998 | 23 | |
| 19 | 1998 | 22 | |
| 20 | 2006 | 22 |
About Tianbao Lu
Tianbao Lu is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Hematology and Genetics, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Chemical Synthesis and Analysis (8 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Synthesis and Catalytic Reactions (4 papers), Microtubule and mitosis dynamics (3 papers), Cancer Mechanisms and Therapy (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Organic Chemistry (432 citations), Oncology (337 citations), Pharmaceutical Science (62 citations), Hematology (103 citations) and Biotechnology (78 citations). Tianbao Lu has collaborated with scholars based in United States, China and Belgium. Frequent co-authors include Daniel J. Parks, Maxwell D. Cummings, Karen L. Milkiewicz, Raul R. Calvo, Jennifer Lattanze, Juan Marugán, Louis V. LaFrance, Mark R. Player, Bruce E. Tomczuk and Bruce Grasberger. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Cancer Research, Tetrahedron Letters and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.